My order got filled at ask 1000 patients is less than 1% of sufferers in Australia that’s $10mil quarterly- what’s great is this is a recurring revenue stream If next quarter they have 200 @ $2nil then pick up 500 more next quarter 4th quarter will have $7mil revenue just from Cannepil. The VC deal is great- Cannepil is the $$$$ Market MGCLF